Oncology Services:Clinical Trials
Current Clinical Trials
S1007 — A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
A Prospective Surveillance Study to Promote Optimal Function During Breast Cancer Survivorship -- Patients to be evaluated pre-surgery by Physical Therapy. Call 331-221-6044 with questions.
CALGB 80702 A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer
LUNG, NONSMALL CELL, METASTATIC
E5508 — Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
MDS/ MULTIPLE MYELOMA
E2905 — Randomized Phase II Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate-1 Risk MDS and Symptomatic Anemia (Accrual of new patients is suspended until Addendum 10 and the related informed consent document, both of which update the risk profile, are acknowledged by the EEH IRB. This will most likely be in mid-January.)
Connect MM —Registry for patients with a new diagnosis of multiple myeloma; patients are followed for up to 8 years.
Rssearch Cyberknife Patient Registry - Registry for any patient treated with SBRS or SBS for cancer
Registry for Prostate Cancer Radiosurgery - Registry for any patient treated with SBRS or SBS for prostate cancer
Please contact the Research Nurse Navigator at 331-221-2162 for more details.